FUSION PROTEIN COMPRISING A SURFACTANT-PROTEIN-D AND A MEMBER OF THE TNFSF

SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS

MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE

SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS

LUNG TREATMENT COMPOSITIONS

SURFACTANT FORMULATIONS FOR INHALATION

POLYPEPTIDES HAVING IMPROVED PROPERTIES

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE

SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS

METHOD FOR TREATING INFECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)

Nanocarriers for lung inflammation therapy

RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION

SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS

METHODS, COMPOSITIONS AND CELLS FOR PREPARING SURFACTANT PROTEIN D (SP-D)

Immunogenic Composition

SURFACTANT FORMULATIONS FOR INHALATION

Permanent gene correction by means of nucleotide-modified messenger RNA

Nanocage and use thereof

Synthetic lung surfactant with enhanced stability and effectiveness

Methods, compositions and cells for preparing surfactant protein D (SP-D)

Composition comprised of antigen linked to a TNF superfamily ligand

Treating infection

NOVEL POLYPEPTIDE AND USES THEREOF

PRODUCTION OF HUMAN PULMONARY SURFACTANT PROTEIN B IN PLANTS

RNA with a combination of unmodified and modified nucleotides for protein expression

Composition comprised of antigen linked to a TNF superfamily ligand

Synthetic promoter construct for transgene expression

Lyophilization of synthetic liposomal pulmonary surfactant

Surfactant protein D for the treatment of disorders associated with lung injury

Alpha-1 antitrypsin variant, preparation method thereof and use thereof

Fire extinguishing agent and fire extinguishing method using same

Compound and method for treatment of Alzheimer's disease

Reconstituted pulmonary surfactants

Lyophilization of synthetic liposomal pulmonary surfactant

Lyophilization of synthetic liposomal pulmonary surfactant

Synthetic lung surfactant and use thereof

METHOD FOR THE PREPARATION OF SURFACTANT PEPTIDES

Peptide Inhibitors and Methods of Use Thereof

Reconstituted surfactants having improved properties

ALKYLATED SP-B PEPTOID COMPOUNDS AND RELATED LUNG SURFACTANT COMPOSITIONS

Polypeptoid pulmonary surfactants

RNA WITH A COMBINATION OF UNMODIFIED AND MODIFIED NUCLEOTIDES FOR PROTEIN EXPRESSION

Treatment and prevention of pulmonary conditions

Methods for treatment of Alzheimer's disease

Recombinant surfactant protein D compositions and methods of use thereof

ADIPONECTIN FOR TREATING PULMONARY DISEASE

Artifical Pulmonary Surfactant Compositions

Surfactant protein D for the treatment of disorders associated with lung injury

Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)

Synthetic lung surfactant and use thereof

Reconstituted surfactants having improved properties

Chimeric plasminogen activators and their pharmaceutical use

Collectin

Liquid phase peptide synthesis of KL-4 pulmonary surfactant

Method of stabilizing pulmonary surfactant protein

Reconstituted surfactants having improved properties

Synthetic pulmonary surfactant peptides

SURFACTANT PROTEIN-D FOR PREVENTION AND TREATMENT OF LUNG INFECTIONS AND SEPSIS

Synthetic lipid mixtures for the preparation of a reconstituted surfactant

Liquid phase peptide syntheses of KL-4 pulmonary surfactant

Pulmonary surfactant formulations

Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation

Surfactant protein C esters

Liquid phase peptide synthesis of KL-4 pulmonary surfactant

Polypeptoid pulmonary surfactants

Synthetic lipid mixtures for the preparation of a reconstituted surfactant

Compositions for treatment and prevention of pulmonary conditions